Saba NF - Search Results

1

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML. Ferris RL, et al. Among authors: saba nf. N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8. N Engl J Med. 2016. PMID: 27718784 Free PMC article. Clinical Trial.

2

Moving toward bioadjuvant approaches to head and neck cancer prevention.

Saba NF, Hammond A, Shin DM, Khuri FR. Saba NF, et al. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S132-5. doi: 10.1016/j.ijrobp.2007.05.041. Int J Radiat Oncol Biol Phys. 2007. PMID: 17848282 Review.

3

Targeting angiogenesis in head and neck cancer.

Saba NF, Shin DM, Khuri FR. Saba NF, et al. Curr Cancer Drug Targets. 2007 Nov;7(7):643-9. doi: 10.2174/156800907782418356. Curr Cancer Drug Targets. 2007. PMID: 18045069 Review.

4

Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.

Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, Chen Z. Muller S, et al. Cancer. 2008 Jul 1;113(1):97-107. doi: 10.1002/cncr.23557. Cancer. 2008. PMID: 18473353 Free article.

5

Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.

Saba NF, Wang X, Müller S, Tighiouart M, Cho K, Nie S, Chen Z, Shin DM. Saba NF, et al. Head Neck. 2009 Apr;31(4):475-81. doi: 10.1002/hed.21003. Head Neck. 2009. PMID: 19072997 Free PMC article.

6

Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents.

Saba NF, Khuri FR. Saba NF, et al. Curr Opin Oncol. 2009 May;21(3):232-7. doi: 10.1097/cco.0b013e32832a56b3. Curr Opin Oncol. 2009. PMID: 19370807 Review.

7

Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.

Saba NF, Edelman S, Tighiouart M, Gaultney J, Davis LW, Khuri FR, Chen A, Grist W, Shin DM. Saba NF, et al. Head Neck. 2009 Nov;31(11):1447-55. doi: 10.1002/hed.21120. Head Neck. 2009. PMID: 19431199

8

Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation.

Lawson JD, Gaultney J, Saba N, Grist W, Davis L, Johnstone PA. Lawson JD, et al. Am J Otolaryngol. 2009 Jul-Aug;30(4):244-9. doi: 10.1016/j.amjoto.2008.06.010. Epub 2009 Feb 6. Am J Otolaryngol. 2009. PMID: 19563935

9

Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.

Saba NF, Choi M, Muller S, Shin HJ, Tighiouart M, Papadimitrakopoulou VA, El-Naggar AK, Khuri FR, Chen ZG, Shin DM. Saba NF, et al. Cancer Prev Res (Phila). 2009 Sep;2(9):823-9. doi: 10.1158/1940-6207.CAPR-09-0077. Epub 2009 Sep 8. Cancer Prev Res (Phila). 2009. PMID: 19737986 Free PMC article.

10

Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.

Xu J, Müller S, Nannapaneni S, Pan L, Wang Y, Peng X, Wang D, Tighiouart M, Chen Z, Saba NF, Beitler JJ, Shin DM, Chen ZG. Xu J, et al. Among authors: saba nf. Eur J Cancer. 2012 Jul;48(11):1682-91. doi: 10.1016/j.ejca.2011.12.029. Epub 2012 Feb 15. Eur J Cancer. 2012. PMID: 22341992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page